[Skip to Content]

Upstate Active Clinical Trials

Study Title:

S2104 - Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Upstate Institutional Review Board (IRB) Number:

1947027

Study/Protocol ID:

S2104

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Rahul Seth, DO

What is involved if I participate?

  • How long is the study?
    5 years
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No
  • What tests and procedures are involved?
    Surgery, CTs and/or MRIs, Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP)

Where will the study take place?

Upstate University Hospital - Downtown Campus

ClinicalTrials.Gov ID:

NCT05040360

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Amelia Bell
Phone: 315-464-5777
Email: [email protected]

Return to Previous Page || Search Again

Top